Skip to main content
. 2016 Dec 27;8(6):9911–9921. doi: 10.18632/oncotarget.14253

Table 2. Logistic regression analysis for poor overall response to the organ preservation protocol (for the ‘validation set’ patients).

Variable Adjusted OR* (95% CI) p-value
miR-21expression
Low expression 1 (ref.) 0.023
High expression 5.69 (1.27 – 25.58)
Tumor Staging
CS III 1 (ref.) 0.025
CS IV 5.05 (1.22 – 20.88)

*Adjusted by age, tumor site, p16 immunoexpression and tumor resectability